BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9462266)

  • 21. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells.
    Nishimura R; Moriyama K; Yasukawa K; Mundy GR; Yoneda T
    J Bone Miner Res; 1998 May; 13(5):777-85. PubMed ID: 9610741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoassay for functional human soluble interleukin-6 receptor in plasma based on ligand/receptor interactions.
    Montero-Julian FA; Liautard J; Flavetta S; Romagné F; Gaillard JP; Brochier J; Klein B; Brailly H
    J Immunol Methods; 1994 Feb; 169(1):111-21. PubMed ID: 8133069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity.
    Papadaki H; Kyriakou D; Foudoulakis A; Markidou F; Alexandrakis M; Eliopoulos GD
    Acta Haematol; 1997; 97(4):191-5. PubMed ID: 9158660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer.
    Okugawa Y; Miki C; Toiyama Y; Yasuda H; Yokoe T; Saigusa S; Hiro J; Tanaka K; Inoue Y; Kusunoki M
    Br J Cancer; 2010 Sep; 103(6):787-95. PubMed ID: 20823887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction.
    Ueda K; Takahashi M; Ozawa K; Kinoshita M
    Am Heart J; 1999 Nov; 138(5 Pt 1):908-15. PubMed ID: 10539822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
    Gaillard JP; Liautard J; Klein B; Brochier J
    Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes.
    Giuliani N; Sansoni P; Girasole G; Vescovini R; Passeri G; Passeri M; Pedrazzoni M
    Exp Gerontol; 2001 Mar; 36(3):547-57. PubMed ID: 11250125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
    J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of soluble interleukin-2 receptor in renal cell carcinoma.
    Matsumoto T; Furukawa A; Sumiyoshi Y; Akiyama KY; Kanayama HO; Kagawa S
    Urology; 1998 Jan; 51(1):145-9. PubMed ID: 9457310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.
    Blay JY; Negrier S; Combaret V; Attali S; Goillot E; Merrouche Y; Mercatello A; Ravault A; Tourani JM; Moskovtchenko JF
    Cancer Res; 1992 Jun; 52(12):3317-22. PubMed ID: 1596890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia.
    Goette NP; Lev PR; Heller PG; Glembotsky AC; Chazarreta CD; Salim JP; Molinas FC; Marta RF
    Exp Hematol; 2010 Oct; 38(10):868-876.e1. PubMed ID: 20600579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble interleukin-6 receptor, interleukin-10 and granulocyte colony-stimulating factor in acute pyelonephritis: relationship to markers of bacterial virulence and renal function.
    Jacobson SH; Lu Y; Brauner A
    Nephron; 1998 Dec; 80(4):401-7. PubMed ID: 9832638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Viscum album extract therapy in patients with cancer: relation with interleukin-6, soluble interleukin-6 receptor, and soluble gp130.
    Kovacs E
    J Altern Complement Med; 2004 Apr; 10(2):241-6. PubMed ID: 15165404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
    Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y
    Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
    Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of IL-6 protein expression in primary human renal cell carcinoma: an immunohistochemical study.
    Paule B; Belot J; Rudant C; Coulombel C; Abbou CC
    J Clin Pathol; 2000 May; 53(5):388-90. PubMed ID: 10889822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients.
    Memoli B; Postiglione L; Cianciaruso B; Bisesti V; Cimmaruta C; Marzano L; Minutolo R; Cuomo V; Guida B; Andreucci M; Rossi G
    Kidney Int; 2000 Jul; 58(1):417-24. PubMed ID: 10886590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy.
    Hoheisel G; Izbicki G; Roth M; Chan CH; Reichenberger F; Schauer J; Perruchoud AP
    Respiration; 1998; 65(3):183-6. PubMed ID: 9670298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.